Christy J. Oliger is a director of Reata Pharmaceuticals Inc.
Person profile
Roles
Address
Newton, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Replimune Group, Inc.
3 Apr 24
4
RayzeBio, Inc.
27 Feb 24
4
REATA PHARMACEUTICALS INC
26 Sep 23
3
RayzeBio, Inc.
14 Sep 23
4
REATA PHARMACEUTICALS INC
9 Jun 23
4
Karyopharm Therapeutics Inc.
25 May 23
4
Replimune Group, Inc.
4 Apr 23
4
Sierra Oncology, Inc.
1 Jul 22
4
REATA PHARMACEUTICALS INC
9 Jun 22
4
Karyopharm Therapeutics Inc.
20 May 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | REPL Replimune | Stock Option Common Stock | Grant | Acquire A | No | No | 7.73 | 32,000 | 247.36 k | 32,000 |
26 Feb 24 | RYZB RayzeBio | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 10.39 | 114,579 | 1.19 mm | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Class A common stock | Sale back to company | Dispose D | No | No | 0 | 5,565 | 0.00 | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 93.61 | 2,137 | 200.04 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 34.76 | 5,620 | 195.35 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 146.01 | 180 | 26.28 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 146.01 | 5,000 | 730.05 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 92.2 | 106 | 9.77 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 92.2 | 10,000 | 922.00 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 92.2 | 1,250 | 115.25 k | 0 |